Cyanocobalamin as Photosensitizing Agent
Condition(s):KeratoconusLast Updated:May 27, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):KeratoconusLast Updated:May 27, 2022Not yet recruiting
Condition(s):Periodontitis; Alveolar Bone LossLast Updated:May 7, 2020Unknown status
Condition(s):Neoplasms, Basal Cell; Carcinoma, Basal Cell; Photochemotherapy; Photosensitizing AgentsLast Updated:March 28, 2019Active, not recruiting
Condition(s):Actinic KeratosesLast Updated:December 6, 2021Withdrawn
Condition(s):Multiple Actinic KeratosesLast Updated:July 11, 2016Completed
Condition(s):Actinic Keratosis; Natural Daylight Photodynamic TherapyLast Updated:August 28, 2019Completed
Condition(s):Actinic KeratosisLast Updated:January 6, 2016Unknown status
Condition(s):Hilar CholangiocarcinomaLast Updated:October 18, 2022Recruiting
Condition(s):Periodontitis; Periodontal InflammationLast Updated:November 18, 2022Completed
Condition(s):Treatment Response; Adverse Events; FeasibilityLast Updated:April 14, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.